2007
DOI: 10.4269/ajtmh.2007.76.334
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Karyotyping of the 2la Inversion in Anopheles Gambiae

Abstract: The African malaria vector Anopheles gambiae is polymorphic for alternative arrangements on the left arm of chromosome 2 (2La and 2L+(a)) that are non-randomly distributed with respect to degree of aridity. Detailed studies on the ecological role of inversion 2La have been hindered by the technical demands of traditional karyotype analysis and by sex- and stage-specific limitations on the availability of polytene chromosomes favorable for analysis. Recent molecular characterization of both inversion breakpoint… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
79
0

Year Published

2009
2009
2024
2024

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 71 publications
(79 citation statements)
references
References 21 publications
0
79
0
Order By: Relevance
“…Hybrids exhibited bands for each species at each of these assays when viewed on agarose gels. Some individuals were also genotyped using a diagnostic for the 2La inversion polymorphism [35]. …”
Section: Methodsmentioning
confidence: 99%
“…Hybrids exhibited bands for each species at each of these assays when viewed on agarose gels. Some individuals were also genotyped using a diagnostic for the 2La inversion polymorphism [35]. …”
Section: Methodsmentioning
confidence: 99%
“…gambiae s.s. was identiÞed using established methods (Favia et al 2001, Fanello et al 2002. 2La genotype was determined using a 2La diagnostic PCR proposed by White et al (2007).…”
Section: Methodsmentioning
confidence: 99%
“…Nowadays, the new advances in molecular karyotyping in An. gambiae (based on quick, low-cost and convenient PCR reactions) have relaunched an interest in this field [87,88] AFUB25 AY029723 GTGGAAACGGTGGTACTGT CGCCATGTAGCTAGGGTTTG 212-224 AFUB10 AY029717 TGTCCATGTACAACCGCAAC TTCTCCAGCATCATCAGCAC 195-210 AFND37 AY291373 GATCGATACAATAAGTGTAGAAATAAT TCACGATGTGCAACCTATAA 161-189 AFUB30 AY029737 GCCAGTTTGCAGAACCAAAT CTGCTGCTGATGTTGCTGAT 154-163 AFUB7 AY029714 ATGGGACGATGGATTACCAA GCCAGTTTGCAGAACCAAAT 220-223 AFUB16 AY029723 CGTGGATGGCAATGTTACTG TGCGACTTATCAGTGCTCCT 179-209 AFND21 AF171051 CCGCACACCAACTTACACTC TGGCGTGGGATTAAATAGG 96-104 AFUB13 GACTTCCGCCACAGAACATC CTCAGGCTCGCAGTAGGAGT 207-210 AFND19 AF171049 CAGAACCACTTCGATTCAAC CCTGCACTCAGAAACACAC 172-205 FUND AY6008 GCTAACTACTCCGAAGCGCT GATCGCAAAACTTCCGGTT 145-177 FUNI AY6013 *GCAACTAAGCTGGGACAGGA GCATCTAACCCTGCTGCTT 181-197 AFND3 AF171033 ACGACTGTAACCACAACACC TAGTAGCGAAGGCGAAAGAT 171-195 FUNF AY6010 CCTTCAGTTTCGATTGGCG AATAAGATGCGACCGTGGC 104-118 AFND10 AF171040 TTTTTTCTTCCCGTGTTGC TACCATTTGATTACAGCGCC 114-146 AFUB17 AY029724 GAAAACCGTACGAACGATGG TGCGACAGTAGCACAGGGTA 187-196 AFUB1 AY029708 CAGCAGCAGCAGCAACAG GACGTTAGCATCTCCACCAG 266-269 AFUB12 AY029719 TGGGGAAC...…”
Section: Molecular Markersmentioning
confidence: 99%